ADPT earnings call for the period ending June 30, 2020.
News & Analysis: Adaptive Biotechnologies Corporation
Investors expect the company's technology platform to come in handy as the world corrals the coronavirus pandemic.
The genetic diagnostics company announced the pricing of a common stock offering that suggests there's solid demand for shares.
The diagnostic company reported second-quarter 2019 operating results, but shares tumbled in early September.